当前位置：
X-MOL 学术
›
Antimicrob. Agents Chemother.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Letter to the Editor on: “Population Pharmacokinetics of Dalbavancin and Dosing Considerations for Optimal Treatment of Adult Patients with Staphylococcal Osteoarticular Infections”.
Antimicrobial Agents and Chemotherapy ( IF 4.1 ) Pub Date : 2021-10-18 , DOI: 10.1128/aac.01493-21 S Baklouti 1, 2 , S Marolleau 2 , P Chavanet 3 , E Bonnet 4 , D Concordet 2 , P Gandia 1, 2
Antimicrobial Agents and Chemotherapy ( IF 4.1 ) Pub Date : 2021-10-18 , DOI: 10.1128/aac.01493-21 S Baklouti 1, 2 , S Marolleau 2 , P Chavanet 3 , E Bonnet 4 , D Concordet 2 , P Gandia 1, 2
Affiliation
Dear Editor,Recently, Cojutti et al. [1] published a population pharmacokinetic (POP PK) model
on dalbavancin administered to adult patients with Staphylococcal osteoarticular infections
(OAI).…
中文翻译：
致编辑的信：“达巴万星的群体药代动力学和成年葡萄球菌骨关节感染患者最佳治疗的剂量考虑”。
亲爱的编辑，最近，Cojutti 等人。[1] 发表了对葡萄球菌骨关节感染 (OAI) 成年患者施用达巴万星的群体药代动力学 (POP PK) 模型。...
更新日期：2021-10-20
中文翻译：
致编辑的信：“达巴万星的群体药代动力学和成年葡萄球菌骨关节感染患者最佳治疗的剂量考虑”。
亲爱的编辑，最近，Cojutti 等人。[1] 发表了对葡萄球菌骨关节感染 (OAI) 成年患者施用达巴万星的群体药代动力学 (POP PK) 模型。...
京公网安备 11010802027423号